Virtus Fund Advisers, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus Fund Advisers, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$106,242
+21.0%
1,186
+15.0%
0.75%
+21.5%
Q2 2023$87,779
+2.9%
1,0310.0%0.62%
+3.5%
Q1 2023$85,315
+5.2%
1,0310.0%0.60%
+2.9%
Q4 2022$81,088
-48.4%
1,031
-76.8%
0.58%
+58100.0%
Q2 2014$157,0004,4410.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2014
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders